Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi The role of cannabis-based medications in managing opioid epidemics: translating evidence for policy makers
*Corresponding Author:
Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 2020 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Objective: The main objective of this presentation is to translate the scarce available clinical data about medical cannabis into more tangible information for policy makers (cost saving, impact of absenteeism, productivity loss) in order to convince them to allocate more resources toward research on CBMs. It can also give a new perspective to clinicians who are interested in commercializing their research results because unmet clinical needs will be addressed in the presentation. Methodology: the data on cost-effectiveness and societal impact of prescription opioids and opioid substitution treatments will be added to data about the efficacy of CBMs in controlling chronic pain to build a case for more resource allocation
